Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Assessment of Perfluorooctane Sulfonate and Perfluorooctanoic Acid Exposure Through Fish Consumption in Italy.

Barbarossa A, Gazzotti T, Farabegoli F, Mancini FR, Zironi E, Busani L, Pagliuca G.

Ital J Food Saf. 2016 Nov 2;5(4):6055. doi: 10.4081/ijfs.2016.6055. eCollection 2016 Sep 20.

2.

A review of contamination of surface-, ground-, and drinking water in Sweden by perfluoroalkyl and polyfluoroalkyl substances (PFASs).

Banzhaf S, Filipovic M, Lewis J, Sparrenbom CJ, Barthel R.

Ambio. 2017 Apr;46(3):335-346. doi: 10.1007/s13280-016-0848-8. Epub 2016 Nov 14. Review.

3.

Detection of Poly- and Perfluoroalkyl Substances (PFASs) in U.S. Drinking Water Linked to Industrial Sites, Military Fire Training Areas, and Wastewater Treatment Plants.

Hu XC, Andrews DQ, Lindstrom AB, Bruton TA, Schaider LA, Grandjean P, Lohmann R, Carignan CC, Blum A, Balan SA, Higgins CP, Sunderland EM.

Environ Sci Technol Lett. 2016 Oct 11;3(10):344-350. Epub 2016 Aug 9.

4.

Persistent Organic Pollutants and the Association with Maternal and Infant Thyroid Homeostasis: A Multipollutant Assessment.

Berg V, Nøst TH, Pettersen RD, Hansen S, Veyhe AS, Jorde R, Odland JØ, Sandanger TM.

Environ Health Perspect. 2017 Jan;125(1):127-133. doi: 10.1289/EHP152. Epub 2016 May 24.

5.

The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

Beggs KM, McGreal SR, McCarthy A, Gunewardena S, Lampe JN, Lau C, Apte U.

Toxicol Appl Pharmacol. 2016 Aug 1;304:18-29. doi: 10.1016/j.taap.2016.05.001. Epub 2016 May 3.

6.

Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study.

Yang L, Li J, Lai J, Luan H, Cai Z, Wang Y, Zhao Y, Wu Y.

Sci Rep. 2016 Feb 22;6:21699. doi: 10.1038/srep21699.

7.

Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies.

Papadopoulou E, Haug LS, Sabaredzovic A, Eggesbø M, Longnecker MP.

Environ Res. 2015 Jul;140:421-9. doi: 10.1016/j.envres.2015.04.022. Epub 2015 May 15.

8.

Elevated levels of perfluoroalkyl acids in family members of occupationally exposed workers: the importance of dust transfer.

Fu J, Gao Y, Wang T, Liang Y, Zhang A, Wang Y, Jiang G.

Sci Rep. 2015 Mar 20;5:9313. doi: 10.1038/srep09313.

9.

Acute Immunotoxic Effects of Perfluorononanoic Acid (PFNA) in C57BL/6 Mice.

Rockwell CE, Turley AE, Cheng X, Fields PE, Klaassen CD.

Clin Exp Pharmacol. 2013;Suppl 4. pii: S4-002.

10.

Pregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective study.

Høyer BB, Ramlau-Hansen CH, Obel C, Pedersen HS, Hernik A, Ogniev V, Jönsson BA, Lindh CH, Rylander L, Rignell-Hydbom A, Bonde JP, Toft G.

Environ Health. 2015 Jan 7;14:2. doi: 10.1186/1476-069X-14-2.

11.

Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California.

Wu XM, Bennett DH, Calafat AM, Kato K, Strynar M, Andersen E, Moran RE, Tancredi DJ, Tulve NS, Hertz-Picciotto I.

Environ Res. 2015 Jan;136:264-73. doi: 10.1016/j.envres.2014.09.026. Epub 2014 Nov 20.

12.

Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Starling AP, Engel SM, Richardson DB, Baird DD, Haug LS, Stuebe AM, Klungsøyr K, Harmon Q, Becher G, Thomsen C, Sabaredzovic A, Eggesbø M, Hoppin JA, Travlos GS, Wilson RE, Trogstad LI, Magnus P, Longnecker MP.

Am J Epidemiol. 2014 Apr 1;179(7):824-33. doi: 10.1093/aje/kwt432. Epub 2014 Feb 20.

13.

Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Corsini E, Luebke RW, Germolec DR, DeWitt JC.

Toxicol Lett. 2014 Oct 15;230(2):263-70. doi: 10.1016/j.toxlet.2014.01.038. Epub 2014 Feb 3. Review.

14.

Recent developments in methods for analysis of perfluorinated persistent pollutants.

Trojanowicz M, Koc M.

Mikrochim Acta. 2013;180:957-971. Epub 2013 Jul 17.

15.

Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, Clewell HJ 3rd.

J Toxicol Environ Health A. 2013;76(1):25-57. doi: 10.1080/15287394.2012.722523.

16.

Perfluorinated compounds may lower vaccine protection in children.

Potera C.

Environ Health Perspect. 2012 Apr;120(4):A150-1. doi: 10.1289/ehp.120-a150a. No abstract available.

17.

Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C.

JAMA. 2012 Jan 25;307(4):391-7. doi: 10.1001/jama.2011.2034. Erratum in: JAMA. 2012 Mar 21;307(11):1142.

18.

Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water.

Mondal D, Lopez-Espinosa MJ, Armstrong B, Stein CR, Fletcher T.

Environ Health Perspect. 2012 May;120(5):752-7. doi: 10.1289/ehp.1104538. Epub 2012 Jan 23.

19.

Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Dixon D, Reed CE, Moore AB, Gibbs-Flournoy EA, Hines EP, Wallace EA, Stanko JP, Lu Y, Jefferson WN, Newbold RR, Fenton SE.

Reprod Toxicol. 2012 Jul;33(4):506-12. doi: 10.1016/j.reprotox.2011.10.011. Epub 2011 Nov 28.

20.

Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.

Stein CR, Savitz DA.

Environ Health Perspect. 2011 Oct;119(10):1466-71. doi: 10.1289/ehp.1003538. Epub 2011 Jun 10.

Supplemental Content

Support Center